Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantCommon Stock | 29,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001649245-26-000006 · wk-form4_1773177016.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,949 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Leite JohnChief Commercial Officer-CLIA
|
GrantCommon Stock | 6,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001991536-26-000008 · wk-form4_1773177008.xml · nonDerivative · entry 2 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,339 F2 · kind: Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Leite JohnChief Commercial Officer-CLIA
|
GrantCommon Stock | 36,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001991536-26-000008 · wk-form4_1773177008.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,761 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Stapley MarcDirector · Chief Executive Officer
|
GrantCommon Stock | 92,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000012 · wk-form4_1773177000.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,653 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:09 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 13,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001823563-26-000008 · wk-form4_1773176995.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,534 F2 · kind: Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:09 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 36,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001823563-26-000008 · wk-form4_1773176995.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,377 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 1,664 | $36.34 | $60,468.60 |
DisclosureSEC source: 0001914620-26-000006 · wk-form4_1772832761.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,706 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.17 to $36.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 4,994 | $35.29 | $176,256.24 |
DisclosureSEC source: 0001914620-26-000006 · wk-form4_1772832761.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,370 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:33 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 13,941 | $36.33 | $506,459.80 |
DisclosureSEC source: 0001823563-26-000006 · wk-form4_1772832781.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,196 F1 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.01 to $36.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:33 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 4,400 | $35.55 | $156,409.44 |
DisclosureSEC source: 0001823563-26-000006 · wk-form4_1772832781.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,137 F1 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.99. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC |
Stapley MarcDirector · Chief Executive Officer
|
SaleCommon Stock | 26,279 | $36.28 | $953,367.96 |
DisclosureSEC source: 0001539796-26-000010 · wk-form4_1772832775.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 357,554 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.01 to $36.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC |
Stapley MarcDirector · Chief Executive Officer
|
SaleCommon Stock | 19,244 | $35.56 | $684,226.19 |
DisclosureSEC source: 0001539796-26-000010 · wk-form4_1772832775.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,833 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $36.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC |
Leite JohnChief Commercial Officer-CLIA
|
SaleCommon Stock | 5,260 | $35.19 | $185,082.57 |
DisclosureSEC source: 0001991536-26-000006 · wk-form4_1772832769.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,580 F1 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.53. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 6,902 | $36.01 | $248,541.02 |
DisclosureSEC source: 0001914620-26-000004 · wk-form4_1772659026.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,364 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 7,234 | $36.01 | $260,496.34 |
DisclosureSEC source: 0001823563-26-000004 · wk-form4_1772659015.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,537 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 3,006 | $36.01 | $108,246.06 |
DisclosureSEC source: 0001584145-26-000002 · wk-form4_1772659020.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,909 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. F2 · balance_after: Includes 495 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 7,517 | $36.01 | $270,687.17 |
DisclosureSEC source: 0001991536-26-000004 · wk-form4_1772659009.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,840 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
SaleCommon Stock | 13,425 | $36.16 | $485,429.21 |
DisclosureSEC source: 0001649245-26-000004 · wk-form4_1772659004.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,346 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.78 to $36.65. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
Tax withholdingCommon Stock | 6,035 | $36.01 | $217,320.35 |
DisclosureSEC source: 0001649245-26-000004 · wk-form4_1772659004.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,771 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 19,455 | $36.01 | $700,574.55 |
DisclosureSEC source: 0001539796-26-000008 · wk-form4_1772658996.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,077 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 10,867 | $38.75 | $421,096.25 |
DisclosureSEC source: 0001914620-26-000002 · wk-form4_1772488366.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,266 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC |
McGuire AnnieSVP, General Counsel
|
GrantCommon Stock | 50,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000002 · wk-form4_1772488366.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,133 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 21,071 PSUs vested on February 26, 2026, and the remaining 29,928 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. F2 · balance_after: Includes 374 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 8,905 | $38.75 | $345,068.75 |
DisclosureSEC source: 0001991536-26-000002 · wk-form4_1772488394.xml · nonDerivative · entry 2 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,357 F2 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Leite JohnChief Commercial Officer-CLIA
|
GrantCommon Stock | 47,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001991536-26-000002 · wk-form4_1772488394.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,262 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 17,221 PSUs vested on February 26, 2026, and the remaining 29,928 vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 35,841 | $38.75 | $1,388,838.75 |
DisclosureSEC source: 0001539796-26-000006 · wk-form4_1772488388.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,532 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Stapley MarcDirector · Chief Executive Officer
|
GrantCommon Stock | 139,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000006 · wk-form4_1772488388.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,373 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 70,239 PSUs vested on February 26, 2026, and the remaining 68,835 PSUs will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. F2 · balance_after: Includes 696 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
Tax withholdingCommon Stock | 24,486 | $38.75 | $948,832.50 |
DisclosureSEC source: 0001649245-26-000002 · wk-form4_1772488374.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,806 F2 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantCommon Stock | 71,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001649245-26-000002 · wk-form4_1772488374.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,292 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 47,863 PSUs vested on February 26, 2026, and the remaining 23,943 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 12,049 | $38.75 | $466,898.75 |
DisclosureSEC source: 0001823563-26-000002 · wk-form4_1772488380.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,771 F2 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC |
Chambers RebeccaChief Financial Officer
|
GrantCommon Stock | 59,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001823563-26-000002 · wk-form4_1772488380.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,820 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 23,411 PSUs vested on February 26, 2026, and the remaining 35,913 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:35 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 100 | $43.68 | $4,368.00 |
DisclosureSEC source: 0001914620-25-000012 · wk-form4_1766007307.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,760 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:35 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 10,639 | $43.13 | $458,835.60 |
DisclosureSEC source: 0001914620-25-000012 · wk-form4_1766007307.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,860 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.62 to $43.59. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · derivative · entry 7 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · derivative · entry 6 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 800 | $46.59 | $37,271.84 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · nonDerivative · entry 5 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,554 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.32 to $46.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 12,808 | $45.84 | $587,080.30 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · nonDerivative · entry 4 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,354 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $45.28 to $46.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 6,392 | $44.52 | $284,571.20 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · nonDerivative · entry 3 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,162 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $44.22 to $44.91. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.60 | $76,000.00 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:34 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 10,000 | $7.94 | $79,400.00 |
DisclosureSEC source: 0001231845-25-000007 · wk-form4_1765229667.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 702 | $47.51 | $33,352.02 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,499 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 720 | $47.10 | $33,908.76 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,201 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.50 to $47.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 4,741 | $47.25 | $224,008.93 |
DisclosureSEC source: 0001823563-25-000007 · wk-form4_1764895449.xml · nonDerivative · entry 3 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,496 F2 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $47.05 to $47.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 8,537 | $46.61 | $397,946.28 |
DisclosureSEC source: 0001823563-25-000007 · wk-form4_1764895449.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,237 F2 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.04 to $47.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:43 UTC |
Leite JohnChief Commercial Officer-CLIA
|
SaleCommon Stock | 1,278 | $47.51 | $60,717.78 |
DisclosureSEC source: 0001991536-25-000008 · wk-form4_1764895432.xml · nonDerivative · entry 2 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,113 F2 · kind: The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
Stapley MarcDirector · Chief Executive Officer
|
SaleCommon Stock | 3,220 | $47.35 | $152,462.17 |
DisclosureSEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,603 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $47.23 to $47.49. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC |
Stapley MarcDirector · Chief Executive Officer
|
SaleCommon Stock | 4,448 | $46.90 | $208,613.42 |
DisclosureSEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 321,823 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.22 to $47.21. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:44 UTC |
McGuire AnnieSVP, General Counsel
|
Tax withholdingCommon Stock | 3,052 | $46.16 | $140,880.32 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,921 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:44 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
Tax withholdingCommon Stock | 2,955 | $46.16 | $136,402.80 |
DisclosureSEC source: 0001649245-25-000007 · wk-form4_1764895467.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,486 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:44 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,384 | $46.16 | $156,205.44 |
DisclosureSEC source: 0001823563-25-000007 · wk-form4_1764895449.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,774 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:43 UTC |
Leite JohnChief Commercial Officer-CLIA
|
Tax withholdingCommon Stock | 2,900 | $46.16 | $133,864.00 |
DisclosureSEC source: 0001991536-25-000008 · wk-form4_1764895432.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,391 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.